

Treatments
We offer a comprehensive range of mental health services designed to support your well-being and recovery journey. Richmond Brain & Behavior specializes in Transcranial Magnetic Stimulation (TMS) therapy, general psychiatry, ketamine therapy, and medication management. Our personalized treatment plans are tailored to each individual's needs. Whether you're seeking support for depression, anxiety, OCD, or other mental health concerns, our experienced team provides compassionate, evidence-based care in a safe and welcoming environment.
​

TMS Therapy
Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA-cleared treatment for depression and OCD. It uses targeted magnetic pulses to stimulate brain areas involved in mood regulation, offering relief when medications aren’t effective. TMS is done in-office, requires no anesthesia, and has minimal downtime.

General Psychiatry
General Psychiatry focuses on diagnosing, treating, and managing a wide range of mental health conditions, including depression, anxiety, bipolar disorder, and more. Treatment plans are personalized and may include therapy, medication, or both, depending on each individual’s needs.

Medication Management
Effective treatment starts with personalized medication management. Dr. Beasley provides thorough evaluations, regular follow-ups, and adjusts medications to optimize results—helping patients achieve stability, minimize side effects, and improve quality of life.

Ketamine Therapy
Ketamine Therapy is a rapid-acting treatment for depression, anxiety, and PTSD. It targets brain receptors involved in mood regulation and is administered in a controlled medical setting, often providing relief within hours.

SPRAVATO®
SPRAVATO® is an FDA-approved nasal spray for adults with treatment-resistant depression or MDD with suicidal thoughts. Given under medical supervision, it targets the brain’s glutamate system and can provide rapid relief when other treatments haven’t worked.
Our Approach to TMS
BrainsWay’s Deep TMS™ stands out as a cutting-edge advancement in transcranial magnetic stimulation, offering clear benefits over older, first-generation TMS systems.
​
With a track record of groundbreaking innovation, extensive clinical studies, and widespread use in clinics and hospitals globally, BrainsWay is pushing the boundaries of Deep TMS into new frontiers, including mental health, neurological disorders, and addiction treatment.
​
Unlike the traditional figure-8 TMS coils, which haven’t evolved much since their debut in 1985, BrainsWay’s specially designed coil delivers deeper, wider-reaching stimulation. This sparks greater neuron activity, reduces the chance of mis-targeting, and boosts treatment success rates. An independent head-to-head study comparing TMS technologies has confirmed the superior clinical edge of Deep TMS over its first-generation counterparts.